Eudaimonia Asset Management »

Terns Pharmaceuticals shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.4M 109k 40.40
2023-03-31 $1.1M 25k 42.93
2022-12-31 $1.3M 128k 10.18

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Terns Pharmaceuticals

BlackRock
Vanguard Group
Vivo Capital
Vestal Point Capital
Adage Capital Partners GP
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors
Nearwater Capital Markets
Citadel Advisors

View all funds holding Terns Pharmaceuticals